| Product Code: ETC9939380 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Blood Clotting Factor Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Blood Clotting Factor Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Blood Clotting Factor Market - Industry Life Cycle |
3.4 United Kingdom (UK) Blood Clotting Factor Market - Porter's Five Forces |
3.5 United Kingdom (UK) Blood Clotting Factor Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 United Kingdom (UK) Blood Clotting Factor Market Revenues & Volume Share, By Test, 2021 & 2031F |
3.7 United Kingdom (UK) Blood Clotting Factor Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 United Kingdom (UK) Blood Clotting Factor Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 United Kingdom (UK) Blood Clotting Factor Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United Kingdom (UK) Blood Clotting Factor Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of blood disorders and clotting factor deficiencies in the UK |
4.2.2 Technological advancements in blood clotting factor therapies |
4.2.3 Growing adoption of recombinant clotting factors over plasma-derived products |
4.3 Market Restraints |
4.3.1 High cost associated with blood clotting factor treatments |
4.3.2 Stringent regulatory requirements for approval of clotting factor products |
4.3.3 Limited accessibility to specialized treatment centers for clotting factor therapies |
5 United Kingdom (UK) Blood Clotting Factor Market Trends |
6 United Kingdom (UK) Blood Clotting Factor Market, By Types |
6.1 United Kingdom (UK) Blood Clotting Factor Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Blood Clotting Factor Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 United Kingdom (UK) Blood Clotting Factor Market Revenues & Volume, By Clinical Laboratory Analysers, 2021- 2031F |
6.1.4 United Kingdom (UK) Blood Clotting Factor Market Revenues & Volume, By Point-Of-Care Testing Analysers, 2021- 2031F |
6.2 United Kingdom (UK) Blood Clotting Factor Market, By Test |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Blood Clotting Factor Market Revenues & Volume, By Prothrombin Time Testing, 2021- 2031F |
6.2.3 United Kingdom (UK) Blood Clotting Factor Market Revenues & Volume, By Fibrinogen Testing, 2021- 2031F |
6.2.4 United Kingdom (UK) Blood Clotting Factor Market Revenues & Volume, By Activated Partial Thromboplastin Time Testing, 2021- 2031F |
6.2.5 United Kingdom (UK) Blood Clotting Factor Market Revenues & Volume, By Activated Clotting Time Testing, 2021- 2031F |
6.2.6 United Kingdom (UK) Blood Clotting Factor Market Revenues & Volume, By D-Dimer Testing, 2021- 2031F |
6.2.7 United Kingdom (UK) Blood Clotting Factor Market Revenues & Volume, By Platelet Function Tests, 2021- 2031F |
6.2.8 United Kingdom (UK) Blood Clotting Factor Market Revenues & Volume, By Heparin and Protamine Dose Response Tests for ACT, 2021- 2031F |
6.2.9 United Kingdom (UK) Blood Clotting Factor Market Revenues & Volume, By Heparin and Protamine Dose Response Tests for ACT, 2021- 2031F |
6.3 United Kingdom (UK) Blood Clotting Factor Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Blood Clotting Factor Market Revenues & Volume, By Mechanical Technology, 2021- 2031F |
6.3.3 United Kingdom (UK) Blood Clotting Factor Market Revenues & Volume, By Optical Technology, 2021- 2031F |
6.3.4 United Kingdom (UK) Blood Clotting Factor Market Revenues & Volume, By Electrochemical Technology, 2021- 2031F |
6.3.5 United Kingdom (UK) Blood Clotting Factor Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United Kingdom (UK) Blood Clotting Factor Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Blood Clotting Factor Market Revenues & Volume, By Bleeding Disorders, 2021- 2031F |
6.4.3 United Kingdom (UK) Blood Clotting Factor Market Revenues & Volume, By Acquired Bleeding Disorders, 2021- 2031F |
6.4.4 United Kingdom (UK) Blood Clotting Factor Market Revenues & Volume, By Von Willebrand Disease, 2021- 2031F |
6.4.5 United Kingdom (UK) Blood Clotting Factor Market Revenues & Volume, By Haemophilia, 2021- 2031F |
6.5 United Kingdom (UK) Blood Clotting Factor Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) Blood Clotting Factor Market Revenues & Volume, By Academic Institutions, 2021- 2031F |
6.5.3 United Kingdom (UK) Blood Clotting Factor Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.4 United Kingdom (UK) Blood Clotting Factor Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.5.5 United Kingdom (UK) Blood Clotting Factor Market Revenues & Volume, By Others, 2021- 2031F |
7 United Kingdom (UK) Blood Clotting Factor Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Blood Clotting Factor Market Export to Major Countries |
7.2 United Kingdom (UK) Blood Clotting Factor Market Imports from Major Countries |
8 United Kingdom (UK) Blood Clotting Factor Market Key Performance Indicators |
8.1 Patient adherence rate to prescribed clotting factor treatment regimens |
8.2 Rate of new product approvals and launches in the UK market |
8.3 Number of research and development initiatives focused on improving clotting factor therapies |
9 United Kingdom (UK) Blood Clotting Factor Market - Opportunity Assessment |
9.1 United Kingdom (UK) Blood Clotting Factor Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United Kingdom (UK) Blood Clotting Factor Market Opportunity Assessment, By Test, 2021 & 2031F |
9.3 United Kingdom (UK) Blood Clotting Factor Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.4 United Kingdom (UK) Blood Clotting Factor Market Opportunity Assessment, By Application, 2021 & 2031F |
9.5 United Kingdom (UK) Blood Clotting Factor Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United Kingdom (UK) Blood Clotting Factor Market - Competitive Landscape |
10.1 United Kingdom (UK) Blood Clotting Factor Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Blood Clotting Factor Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here